Innovator Spotlight

Sherlock Biosciences

Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.

Sherlock Biosciences is a molecular diagnostics company with a unique platform designed to solve challenges ranging from faster pathogen detection and simpler testing for cancer to improved food safety. Their team and founders include engineering biology pioneers with world-leading expertise in CRISPR and Synthetic Biology, diagnostic industry veterans, and disease-area authorities. The company provides an unparalleled set of capabilities that are transforming molecular diagnostics in clinical and non-clinical settings with better, faster, affordable tests.


Inside the Episode

Innovator Spotlight

Sherlock Biosciences

On Point
Bryan Dechairo on point discussing becoming the first FDA authorized use of CRISPR.
On Point
Bryan Dechairo on point discussing how his investors' focus on global health.
On Point
Bryan Dechairo on point discussing open-source product development enabled by AI.
On Point
Bryan Dechairo on point discussing your future healthcare journey.
On Point
Bryan Dechairo on point discussing the challenges commercializing high-tech, low-cost products.
On Point
Bryan Dechairo on point discussing bending the curve on population health.
On Point
Julie Garlikov on point discussing raising the stakes in the diagnostics industry.
On Point
Bryan Dechairo on point discussing his role as a life sciences CEO.
On Point
Bryan Dechairo on point discussing providing access to health information with diagnostic tests.
On Point
Julie Garlikov on point discussing improving the user experience in diagnostic testing.
On Point
Julie Garlikov on point discussing healthcare access for underserved communities.

Behind the Scenes

Content Card - Just Mighty - Boyd - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But the odds are against you. We help you turn Just Might into Just Mighty.